The clinical significance of interferon inducible protein-10 in chronic hepatitis C patients with genotype I undergoing pegylated interferon and ribavirin therapy

被引：0
|
作者：
Kim, Chung Ho
Kim, Ji Hoon
Jong, Young Kul
Kim, Jeong Han
Choi, Jong Hwan
Hong, Seong Kweon
Ju, Moon Kyung
Lee, Beom Jae
Yim, Hyung Joon
Yeon, Jong Eun
Park, Jong-Jae
Kim, Jae Seon
Bak, Young Tae
Byun, Kwan Soo
机构：
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2008年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A42 / A42
页数：1
相关论文
共 50 条
  • [31] Racial differences in neutrophil count in chronic hepatitis C patients on pegylated interferon/ribavirin therapy
    Markovits, T
    Mokuolu, A
    Daniel, S
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S91 - S92
  • [32] Symptom development and management in patients with chronic hepatitis C on Pegylated interferon and Ribavirin therapy.
    Ghalib, RH
    Levine, C
    Stribling, R
    Kadhim, T
    Gaglio, P
    Duchini, A
    McClelland, T
    HEPATOLOGY, 2001, 34 (04) : 599A - 599A
  • [33] COSTS AND EFFECTS OF DUAL THERAPY WITH PEGYLATED INTERFERON AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C IN GERMANY
    Berg, T.
    Buggisch, P.
    Mauss, S.
    Wedemeyer, H.
    Benter, U.
    Decker-Burgard, S.
    VALUE IN HEALTH, 2012, 15 (07) : A329 - A329
  • [34] Effectiveness of varied dose of pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
    Midha, V.
    Sood, A.
    Hissar, S. S.
    Sood, N.
    Kumar, M.
    Sarin, S. K.
    PROCEEDINGS OF THE 16TH CONFERENCE OF THE ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER, 2006, : 1 - +
  • [35] Safety of pegylated interferon and ribavirin therapy for chronic hepatitis C in patients with sickle cell anemia
    Issa, Hussain
    WORLD JOURNAL OF HEPATOLOGY, 2010, 2 (05) : 180 - 184
  • [36] Treatment of chronic hepatitis C genotype 1 early responders with 36 week pegylated interferon and ribavirin therapy
    Sood, Ajit
    Midha, Vandana
    Goyal, Omesh
    ANNALS OF HEPATOLOGY, 2014, 13 (05) : 503 - 509
  • [37] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Irit Rosen
    Michal Kori
    Orly Eshach Adiv
    Baruch Yerushalmi
    Nataly Zion
    Ron Shaoul
    World Journal of Gastroenterology, 2013, (07) : 1098 - 1103
  • [38] Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection
    Huang, Ching-I
    Huang, Chung-Feng
    Huang, Jee-Fu
    Dai, Chia-Yen
    Yeh, Ming-Lun
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Wang, Liang-Yen
    Yu, Ming-Lung
    Chuang, Wan-Long
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (05) : 1012 - 1018
  • [39] Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C
    S. K. Tohra
    S. Taneja
    S. Ghosh
    B. K. Sharma
    A. Duseja
    R. K. Dhiman
    A. Das
    Y. K. Chawla
    Digestive Diseases and Sciences, 2011, 56
  • [40] Chronic hepatitis C: Retreatment of pegylated interferon/ribavirin nonresponders
    Cardoso, Helder
    Vale, Ana Horta
    Mendes, Margarida
    Bastos, Pedro
    Machado, Artur
    Santos, Carlos
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S192 - S193
12345